Please note that masks are still required in all Blue Ridge Cancer Care offices regardless of vaccination status.
Learn more about this and other current Covid-19 policies.

Research Institute

A Phase 3b Study of asciminib chronic myeloid leukemia

An open label, multi-center Phase IIIb study of asciminib (ABL001) monotherapy in previously treated patients with chronic myeloid leukemia in chronic phase (CML-CP) with and without T315I mutation

Disease Types: Leukemia

Available at: AlleghanyBlacksburgRoanokeSalemWytheville

An open label, multi-center Phase IIIb study of asciminib (ABL001) monotherapy in previously treated patients with chronic myeloid leukemia in chronic phase (CML-CP) with and without T315I mutation 

For more information:

https://clinicaltrials.gov/ct2/show/NCT04666259?term=NCT04666259&draw=2&rank=1